版权说明 操作指南
首页 > 成果 > 详情

Molecular Engineering of NIR-II Excitable Phototheranostic for Mitochondria-Targeted Cancer Photoimmunotherapy

认领
导出
Link by DOI
反馈
分享
QQ微信 微博
成果类型:
期刊论文
作者:
Kang, Qiang;Liu, Fen;Tan, Senyou;Wu, Fan;Liu, Yinying;...
通讯作者:
Chen, Guodong;Wu, Gui-long;Tan, Xiaofeng;Yang, QL
作者机构:
[Wu, Fan; Li, Zelong; Liu, Fen; Tan, Xiaofeng; Chen, Guodong; Wu, Gui-long; Xiong, Jian; Huang, Hejin; Yang, Qinglai; Kang, Qiang; Tan, XF; Liu, Yinying; Tan, Senyou] Univ South China, Affiliated Hosp 1, Hengyang Med Sch, Dept Hepatopancreatobiliary Surg, Hengyang 421001, Hunan, Peoples R China.
[Wu, Fan; Li, Zelong; Liu, Fen; Tan, Xiaofeng; Chen, Guodong; Wu, Gui-long; Xiong, Jian; Huang, Hejin; Yang, Qinglai; Kang, Qiang; Tan, XF; Liu, Yinying; Tan, Senyou] Univ South China, Inst Pharm & Pharmacol, Hengyang Med Sch, Sch Pharmaceut Sci, Hengyang 421001, Hunan, Peoples R China.
[Wu, Fan; Li, Zelong; Liu, Fen; Tan, Xiaofeng; Chen, Guodong; Wu, Gui-long; Xiong, Jian; Huang, Hejin; Yang, Qinglai; Kang, Qiang; Tan, XF; Liu, Yinying; Tan, Senyou] Univ South China, Hengyang Med Sch, NHC Key Lab Birth Defect Res & Prevent, Hengyang 421001, Hunan, Peoples R China.
[Wu, Fan; Li, Zelong; Liu, Fen; Tan, Xiaofeng; Chen, Guodong; Wu, Gui-long; Xiong, Jian; Huang, Hejin; Yang, Qinglai; Kang, Qiang; Tan, XF; Liu, Yinying; Tan, Senyou] Univ South China, Hengyang Med Sch, MOE Key Lab Rare Pediat Dis, Hengyang 421001, Hunan, Peoples R China.
[Liu, Fen; Xiong, Jian; Huang, Hejin; Liu, Yinying; Tan, Senyou] Univ South China, Affiliated Hosp 2, Dept Radiol, Hengyang 421001, Hunan, Peoples R China.
通讯机构:
[Tan, XF; Yang, QL ; Chen, GD; Wu, GL] U
Univ South China, Affiliated Hosp 1, Hengyang Med Sch, Dept Hepatopancreatobiliary Surg, Hengyang 421001, Hunan, Peoples R China.
Univ South China, Inst Pharm & Pharmacol, Hengyang Med Sch, Sch Pharmaceut Sci, Hengyang 421001, Hunan, Peoples R China.
Univ South China, Hengyang Med Sch, NHC Key Lab Birth Defect Res & Prevent, Hengyang 421001, Hunan, Peoples R China.
Univ South China, Hengyang Med Sch, MOE Key Lab Rare Pediat Dis, Hengyang 421001, Hunan, Peoples R China.
语种:
英文
期刊:
JOURNAL OF MEDICINAL CHEMISTRY
ISSN:
0022-2623
年:
2025
卷:
68
期:
7
页码:
7707-7719
基金类别:
Scientific Research Foundation of Hunan Provincial Education Department [22374065]; National Science Foundation of China [2024JJ2047]; Outstanding Youth Foundation of Hunan Province; Aid Program for Science and Technology Innovative Research Team in Higher Educational Institutions of Hunan Province [2024JJ6374]; Natural Science Foundation of Hunan Province of China [24A0606]; Scientific Research Fund of Hunan Province Education Department [4310, 20224310NHYCG01]; University of South China Clinical Research [ZYYD2024CG17]; Central Government Guided Local Science and Technology Development Fund Project in Xinjiang Uygur Autonomous Region [2024WK4008]; Hunan Province Innovation Ecological Construction Plan Science and Technology Assistance Project in Xinjiang Uygur Autonomous Region [SYTG-Y202429]; Health Technology Promotion Project in Xinjiang Uygur Autonomous Region
机构署名:
本校为第一且通讯机构
院系归属:
医学院
药学与生物科学学院
摘要:
The advancement of mitochondria-targeted near-infrared-II (NIR-II) excitable phototheranostics constitutes a promising strategy for improving fluorescence-image-guided cancer phototherapy. However, developing phototheranostic agents that simultaneously combine high-contrast NIR-II fluorescence imaging with effective multimodal therapeutic techniques remains a substantial challenge. Herein, we reported a shielding-donor–acceptor–donor-shielding structured NIR-II phototheranostic (FCD-T) by a molecular engineering strategy, followed by self-ass...

反馈

验证码:
看不清楚,换一个
确定
取消

成果认领

标题:
用户 作者 通讯作者
请选择
请选择
确定
取消

提示

该栏目需要登录且有访问权限才可以访问

如果您有访问权限,请直接 登录访问

如果您没有访问权限,请联系管理员申请开通

管理员联系邮箱:yun@hnwdkj.com